1-7 of 7
Hayley S. Ma
Close
Sort by
Journal Articles

Arsenic Trioxide Synergizes with FLT3 Tyrosine Kinase Inhibitors to Kill FLT3-ITD + Leukemic Cells through Depressed Production and Degradation of FLT3 Protein

Kozo Nagai, MD PhD, Lihong Hou, MD PhD, Li Li, MD PhD, Bao Nguyen, M.S., Courtney M Shirley, PhD, Hayley S Ma, PhD, Mark J. Levis, MD PhD, Amy S. Duffield, MD PhD, Donald Small, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1568.
https://doi.org/10.1182/blood.V128.22.1568.1568
Published: 2016
Journal Articles

FLT3 TKI Are Differentially Affected By Both Plasma Binding and Stromal Survival Factors

Young J David, MD PhD, Hayley S Ma, PhD, Donald Small, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1570.
https://doi.org/10.1182/blood.V128.22.1570.1570
Published: 2016
Journal Articles

Signaling Adaptation to TKI Treatment Reactivates ERK Signaling in FLT3/ITD Leukemia

Joshua Kyle Bruner, Li Li, MD PhD, Hayley S Ma, PhD, Alice Can Ran Qin, Mark J. Levis, MD PhD, Keith W. Pratz, MD, Christine A. Pratilas, MD, Donald Small, MD PhD
Journal: Blood
Blood (2016) 128 (22): 33.
https://doi.org/10.1182/blood.V128.22.33.33
Published: 2016
Journal Articles

All- trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD + leukemia stem cells in vitro and in vivo

Hayley S. Ma, Sarah M. Greenblatt, Courtney M. Shirley, Amy S. Duffield, J. Kyle Bruner, Li Li, Bao Nguyen, Eric Jung, Peter D. Aplan, Gabriel Ghiaur, Richard J. Jones, Donald Small
Journal: Blood
Blood (2016) 127 (23): 2867–2878.
https://doi.org/10.1182/blood-2015-05-646786
Published: 2016
Includes: Supplemental data
Journal Articles

FLT3 Inhibition and Retinoid Signaling Overcome Stromal Protection to Target FLT3/ITD-Expressing Leukemia Stem Cells in the Bone Marrow Microenvironment

Hayley S Ma, PhD, Megan E McCray, BA, Courtney M Shirley, PhD, Amy S. Duffield, MD PhD, J Kyle Bruner, Li Li, PhD, Bao Nguyen, M.S., Sarah Greenblatt, PhD, Eric Jung, BS, Peter D. Aplan, MD, Richard J Jones, MD, Donald Small, MD PhD, Gabriel Ghiaur, MD PhD
Journal: Blood
Blood (2015) 126 (23): 790.
https://doi.org/10.1182/blood.V126.23.790.790
Published: 2015
Journal Articles

TTT-3002 Is Active Against Relapsed/Refractory AML Patient Bone Marrow With FLT3 TKI-Resistance Mutations At Residue D835

Hayley S Ma, Ph.D., Bao Nguyen, M.S., Mark Levis, MD, PhD, Allen B Williams, PhD, Donald Small, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3818.
https://doi.org/10.1182/blood.V122.21.3818.3818
Published: 2013
Journal Articles

All- Trans Retinoic Acid Synergizes With FLT3 Tyrosine Kinase Inhibition To Eliminate FLT3/ITD-Expressing Leukemia Cells

Hayley S Ma, Ph.D., Sarah M Greenblatt, PhD, Eric Jung, B.S., Amy S. Duffield, MD, PhD, Li Li, PhD, Gabriel Ghiaur, MD, PhD, Richard J. Jones, Donald Small, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3960.
https://doi.org/10.1182/blood.V122.21.3960.3960
Published: 2013